In vitro testing services for small-molecule drug candidates

The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Cyprotex US LLC for in vitro testing services for small-molecule drug candidates. The services will be used to facilitate the discovery and development of new agents with demonstrable anticancer activity. The NIH has experience with Cyprotex and believes they can provide the required services. The notice is not a request for competitive quotes, but small businesses may submit a written capability statement to demonstrate their ability to perform the requirement. • The services include in vitro studies, such as those with cells, tissues, and enzymes, to predict the behavior of compounds. • The NIH is looking for a service provider that can meet their standards and provide the required services. • The award is expected to be issued approximately ten days after the date of the notice, unless another vendor is found to have the capability to meet the requirement.